Rudy Mareel is a seasoned healthcare executive with over 30 years of leadership experience in the pharmaceutical and medical technology sectors. He has held senior and board roles at companies including Vivolta, Synthon, Cardinal Health, Royal Numico, and Becton Dickinson. He was CEO of Polyganics from 2013 to 2022, through to its eventual sale. Rudy is Chair of VitalNext and on the Boards of Malin Corporation, Medichem S.A., NutriLeads and Orca Therapeutics. He is also an Advisory Board member to NextGen Ventures.